Click for best price
Bone Mineral Metabolism Disorders Treatment Market Size, Share 2023
Bone minerals are the inorganic compounds of the bone tissue that helps in strengthening the bones with its plate and globular structures. These minerals are formed from carbonated hydroxyapatite. Bone minerals are dynamic in living beings, it is continuously reabsorbed and build anew in the bone remodelling process. Bone functions as storehouse of calcium, from which calcium is continuously withdrawn or stored as a part of homeostasis. Bone mineral metabolism is refers to the maintenance of sufficient concentration of inorganic ions in blood serum irrespective of muscle tissue metabolic activities. Hormones such as parathormone and calcitonin plays vital role in controlling the muscle metabolic activities, these hormones are regulated by neuroendocrine system and produced by parathyroid and thyroid glands in the neck. Malfunction of these glands result in to metabolic in equilibrium and crates the problems of bone mineral metabolism. Bone and mineral density metabolic disorders are abnormalities of bones, caused by calcium, phosphorous, magnesium and vitamin D aberrations leading to several reversible clinical disorders. These disorders are generally treatable if the underlining cause is addressed with corrective treatment methods. These disorders are caused due to genetic or metabolic malfunctions in the body.
This report aims to provide a comprehensive presentation of the global market for Bone and Mineral Metabolism Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bone and Mineral Metabolism Disorders Treatment. This report contains market size and forecasts of Bone and Mineral Metabolism Disorders Treatment in global, including the following market information:
Global Bone and Mineral Metabolism Disorders Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Bone and Mineral Metabolism Disorders Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global bone and mineral metabolism disorders treatment market is undergoing market changes due to the higher competition among local and multinational players and this in turn helped to make treatment cost more economical. With the availability of wide variety of products in various forms and strengths in the bone and mineral metabolism disorders treatment market is expected to change the market dynamics over a given period of forecast. By disease type, sub segment such as osteoporosis and rickets in the global bone and mineral metabolism disorders treatment market are expected to grow in positive traction owing to increased prevalence of the diseases among the post-menopausal women and children in the various regions.
We surveyed the Bone and Mineral Metabolism Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bone and Mineral Metabolism Disorders Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Bone and Mineral Metabolism Disorders Treatment Market Segment Percentages, by Type, 2022 (%)
Bisphosphonates
Estrogens
Phosphate Binders
Non-Calcium, Non-Metal-Based Binder
Metal-Based Binders
Magnesium-Based Binders
Vitamin D Analogs and Supplements
Calcimimetic Agents
Calcium and Magnesium Supplements
Global Bone and Mineral Metabolism Disorders Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Bone and Mineral Metabolism Disorders Treatment Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Global Bone and Mineral Metabolism Disorders Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Bone and Mineral Metabolism Disorders Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bone and Mineral Metabolism Disorders Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Bone and Mineral Metabolism Disorders Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
F. Hoffmann-La Roche
Novartis
Warner Chilcott
Sanofi
AbbVie
Amgen
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bone and Mineral Metabolism Disorders Treatment, market overview.
Chapter 2: Global Bone and Mineral Metabolism Disorders Treatment market size in revenue.
Chapter 3: Detailed analysis of Bone and Mineral Metabolism Disorders Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bone and Mineral Metabolism Disorders Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Bone and Mineral Metabolism Disorders Treatment Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Bone and Mineral Metabolism Disorders Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bone and Mineral Metabolism Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bone and Mineral Metabolism Disorders Treatment Overall Market Size
2.1 Global Bone and Mineral Metabolism Disorders Treatment Market Size: 2022 VS 2029
2.2 Global Bone and Mineral Metabolism Disorders Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Bone and Mineral Metabolism Disorders Treatment Players in Global Market
3.2 Top Global Bone and Mineral Metabolism Disorders Treatment Companies Ranked by Revenue
3.3 Global Bone and Mineral Metabolism Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Bone and Mineral Metabolism Disorders Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Bone and Mineral Metabolism Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bone and Mineral Metabolism Disorders Treatment Players in Global Market
3.6.1 List of Global Tier 1 Bone and Mineral Metabolism Disorders Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Bone and Mineral Metabolism Disorders Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Bone and Mineral Metabolism Disorders Treatment Market Size Markets, 2022 & 2029
4.1.2 Bisphosphonates
4.1.3 Estrogens
4.1.4 Phosphate Binders
4.1.5 Non-Calcium, Non-Metal-Based Binder
4.1.6 Metal-Based Binders
4.1.7 Magnesium-Based Binders
4.1.8 Vitamin D Analogs and Supplements
4.1.9 Calcimimetic Agents
4.1.10 Calcium and Magnesium Supplements
4.2 By Type - Global Bone and Mineral Metabolism Disorders Treatment Revenue & Forecasts
4.2.1 By Type - Global Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2023
4.2.2 By Type - Global Bone and Mineral Metabolism Disorders Treatment Revenue, 2024-2029
4.2.3 By Type - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Bone and Mineral Metabolism Disorders Treatment Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.1.5 Drug Stores
5.2 By Application - Global Bone and Mineral Metabolism Disorders Treatment Revenue & Forecasts
5.2.1 By Application - Global Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2023
5.2.2 By Application - Global Bone and Mineral Metabolism Disorders Treatment Revenue, 2024-2029
5.2.3 By Application - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Bone and Mineral Metabolism Disorders Treatment Market Size, 2022 & 2029
6.2 By Region - Global Bone and Mineral Metabolism Disorders Treatment Revenue & Forecasts
6.2.1 By Region - Global Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2023
6.2.2 By Region - Global Bone and Mineral Metabolism Disorders Treatment Revenue, 2024-2029
6.2.3 By Region - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2029
6.3.2 US Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.3.3 Canada Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.3.4 Mexico Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2029
6.4.2 Germany Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.4.3 France Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.4.4 U.K. Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.4.5 Italy Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.4.6 Russia Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.4.8 Benelux Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2029
6.5.2 China Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.5.3 Japan Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.5.4 South Korea Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.5.6 India Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2029
6.6.2 Brazil Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.6.3 Argentina Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2029
6.7.2 Turkey Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.7.3 Israel Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
6.7.5 UAE Bone and Mineral Metabolism Disorders Treatment Market Size, 2018-2029
7 Bone and Mineral Metabolism Disorders Treatment Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Bone and Mineral Metabolism Disorders Treatment Major Product Offerings
7.1.4 Merck Bone and Mineral Metabolism Disorders Treatment Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 F. Hoffmann-La Roche
7.2.1 F. Hoffmann-La Roche Company Summary
7.2.2 F. Hoffmann-La Roche Business Overview
7.2.3 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Major Product Offerings
7.2.4 F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Revenue in Global Market (2018-2023)
7.2.5 F. Hoffmann-La Roche Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Bone and Mineral Metabolism Disorders Treatment Major Product Offerings
7.3.4 Novartis Bone and Mineral Metabolism Disorders Treatment Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Warner Chilcott
7.4.1 Warner Chilcott Company Summary
7.4.2 Warner Chilcott Business Overview
7.4.3 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Major Product Offerings
7.4.4 Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Revenue in Global Market (2018-2023)
7.4.5 Warner Chilcott Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Bone and Mineral Metabolism Disorders Treatment Major Product Offerings
7.5.4 Sanofi Bone and Mineral Metabolism Disorders Treatment Revenue in Global Market (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 AbbVie
7.6.1 AbbVie Company Summary
7.6.2 AbbVie Business Overview
7.6.3 AbbVie Bone and Mineral Metabolism Disorders Treatment Major Product Offerings
7.6.4 AbbVie Bone and Mineral Metabolism Disorders Treatment Revenue in Global Market (2018-2023)
7.6.5 AbbVie Key News & Latest Developments
7.7 Amgen
7.7.1 Amgen Company Summary
7.7.2 Amgen Business Overview
7.7.3 Amgen Bone and Mineral Metabolism Disorders Treatment Major Product Offerings
7.7.4 Amgen Bone and Mineral Metabolism Disorders Treatment Revenue in Global Market (2018-2023)
7.7.5 Amgen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Bone and Mineral Metabolism Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Bone and Mineral Metabolism Disorders Treatment Market Drivers in Global Market
Table 3. Bone and Mineral Metabolism Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Bone and Mineral Metabolism Disorders Treatment in Global Market
Table 5. Top Bone and Mineral Metabolism Disorders Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Bone and Mineral Metabolism Disorders Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Bone and Mineral Metabolism Disorders Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Bone and Mineral Metabolism Disorders Treatment Product Type
Table 9. List of Global Tier 1 Bone and Mineral Metabolism Disorders Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bone and Mineral Metabolism Disorders Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Bone and Mineral Metabolism Disorders Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Bone and Mineral Metabolism Disorders Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Bone and Mineral Metabolism Disorders Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Bone and Mineral Metabolism Disorders Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Bone and Mineral Metabolism Disorders Treatment Product Offerings
Table 32. Merck Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. F. Hoffmann-La Roche Company Summary
Table 35. F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Product Offerings
Table 36. F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. F. Hoffmann-La Roche Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Bone and Mineral Metabolism Disorders Treatment Product Offerings
Table 40. Novartis Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Warner Chilcott Company Summary
Table 43. Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Product Offerings
Table 44. Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Warner Chilcott Key News & Latest Developments
Table 46. Sanofi Company Summary
Table 47. Sanofi Bone and Mineral Metabolism Disorders Treatment Product Offerings
Table 48. Sanofi Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Bone and Mineral Metabolism Disorders Treatment Product Offerings
Table 52. AbbVie Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. AbbVie Key News & Latest Developments
Table 54. Amgen Company Summary
Table 55. Amgen Bone and Mineral Metabolism Disorders Treatment Product Offerings
Table 56. Amgen Bone and Mineral Metabolism Disorders Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Amgen Key News & Latest Developments
List of Figures
Figure 1. Bone and Mineral Metabolism Disorders Treatment Segment by Type in 2022
Figure 2. Bone and Mineral Metabolism Disorders Treatment Segment by Application in 2022
Figure 3. Global Bone and Mineral Metabolism Disorders Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bone and Mineral Metabolism Disorders Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bone and Mineral Metabolism Disorders Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bone and Mineral Metabolism Disorders Treatment Revenue in 2022
Figure 8. By Type - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 16. US Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 28. China Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Bone and Mineral Metabolism Disorders Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Bone and Mineral Metabolism Disorders Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. F. Hoffmann-La Roche Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Warner Chilcott Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AbbVie Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Amgen Bone and Mineral Metabolism Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
